Weight loss medications like Ozempic, Wegovy, Mounjaro, and Zepbound have been linked to a rare risk of vision loss. Researchers are investigating whether these drugs increase the risk of ischemic optic nerve damage. While there is no direct link between taking these medications and vision loss, some patients have experienced problems with their eyes, including sudden partial vision loss.
The optic nerve is responsible for carrying signals from the eyes to the brain, and loss of blood flow can cause permanent damage. Studies have shown that several patients taking these weight loss medications have experienced a loss of blood flow to the optic nerve or inflammation of the optic nerve head.
To put this risk into perspective, researchers say that fluctuations in blood sugar levels can affect vision temporarily for all diabetic patients. However, some experts warn that people on these medications should be cautious and monitor their vision closely. The manufacturers of these medications have stated that they are still investigating whether these drugs increase the risk of ischemic optic nerve damage.
If you are taking one of these medications and experience vision loss or blurring, it is essential to see an ophthalmologist as soon as possible. While stopping the medication may be necessary in some cases, experts caution against making arbitrary decisions without consulting a doctor.
Source: https://www.independent.co.uk/news/health/ozempic-vision-eye-blindness-risk-b2696901.html